The hallmarks of many haematological malignancies and solid tumours are chromosomal translocations, which may lead to gene fusions. Recently, next-generation sequencing techniques at the transcriptome level (RNA-Seq) have been used to verify known and discover novel transcribed gene fusions. We present FusionFinder, a Perl-based software designed to automate the discovery of candidate gene fusion partners from single-end (SE) or paired-end (PE) RNA-Seq read data. FusionFinder was applied to data from a previously published analysis of the K562 chronic myeloid leukaemia (CML) cell line. Using FusionFinder we successfully replicated the findings of this study and detected additional previously unreported fusion genes in their dataset, which w...
Abstract Background Genomic rearrangements in cancer cells can create fusion genes that encode chime...
Detection of fusion genes for diagnostic purposes and as a guide to treatment is well-established in...
Gene fusions, like BCR/ABL1 in chronic myelogenous leukemia, have long been recognized in hematologi...
The hallmarks of many haematological malignancies and solid tumours are chromosomal translocations, ...
<div><p>The hallmarks of many haematological malignancies and solid tumours are chromosomal transloc...
Abstract Background In cancer, genomic rearrangements can create fusion genes that either combine pr...
Background: Genomic profiling efforts have revealed a rich diversity of oncogenic fusion genes. Whil...
Recurrent oncogenic fusion genes play a critical role in the development of various cancers and dise...
Background: Gene fusions, which result from abnormal chromosome rearrangements, are a pathogenic fac...
Nowadays there exist many bioinformatics tools that analyse sequencing data to identify genetic aber...
Background We have evaluated an NGS-based method to detect recurrent gene fusions of diagnostic and ...
BackgroundUntil recently, chromosomal translocations and fusion genes have been an underappreciated ...
Motivation Fusion genes created by genomic rearrangements can be potent drivers of tumorigenesis. Ho...
Gene fusions are common driver events in leukae-mias and solid tumours; here we present FusionAnalys...
Fusion genes are known to be key drivers of tumor growth in several types of cancer. Traditionally, ...
Abstract Background Genomic rearrangements in cancer cells can create fusion genes that encode chime...
Detection of fusion genes for diagnostic purposes and as a guide to treatment is well-established in...
Gene fusions, like BCR/ABL1 in chronic myelogenous leukemia, have long been recognized in hematologi...
The hallmarks of many haematological malignancies and solid tumours are chromosomal translocations, ...
<div><p>The hallmarks of many haematological malignancies and solid tumours are chromosomal transloc...
Abstract Background In cancer, genomic rearrangements can create fusion genes that either combine pr...
Background: Genomic profiling efforts have revealed a rich diversity of oncogenic fusion genes. Whil...
Recurrent oncogenic fusion genes play a critical role in the development of various cancers and dise...
Background: Gene fusions, which result from abnormal chromosome rearrangements, are a pathogenic fac...
Nowadays there exist many bioinformatics tools that analyse sequencing data to identify genetic aber...
Background We have evaluated an NGS-based method to detect recurrent gene fusions of diagnostic and ...
BackgroundUntil recently, chromosomal translocations and fusion genes have been an underappreciated ...
Motivation Fusion genes created by genomic rearrangements can be potent drivers of tumorigenesis. Ho...
Gene fusions are common driver events in leukae-mias and solid tumours; here we present FusionAnalys...
Fusion genes are known to be key drivers of tumor growth in several types of cancer. Traditionally, ...
Abstract Background Genomic rearrangements in cancer cells can create fusion genes that encode chime...
Detection of fusion genes for diagnostic purposes and as a guide to treatment is well-established in...
Gene fusions, like BCR/ABL1 in chronic myelogenous leukemia, have long been recognized in hematologi...